Press Releases

All Releases
View Summary Myriad Study Reveals Patients Receive Suboptimal Dosing With Chemotherapy Regimens of FOLFOX6 and FOLFOX6 Plus Avastin
Jan 25, 2010
PDF 16.8 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Seventh Annual Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO)
Jan 14, 2010
PDF 13.0 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2010 Second Quarter Financial Results on February 2
Jan 12, 2010
PDF 12.2 KB Add to Briefcase
View Summary Myriad Genetics Partners With Mammography Reporting Systems to Increase Identification of High Risk Breast Cancer Patients
Jan 6, 2010
PDF 16.4 KB Add to Briefcase
View Summary Myriad Genetics to Present at the 28th Annual J.P. Morgan Healthcare Conference
Dec 17, 2009
PDF 12.8 KB Add to Briefcase
View Summary Myriad Genetics to Present at the 21st Annual Piper Jaffray Health Care Conference
Nov 17, 2009
PDF 12.8 KB Add to Briefcase
View Summary Myriad Genetics to Present at Lazard Capital Markets Sixth Annual Healthcare Conference
Nov 4, 2009
PDF 12.8 KB Add to Briefcase
View Summary Myriad Genetics Reports First Quarter Fiscal 2010 Financial Results
Nov 3, 2009
PDF 18.8 KB Add to Briefcase
View Summary Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Oct 15, 2009
PDF 15.7 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2010 First Quarter Financial Results On November 3
Oct 13, 2009
PDF 12.1 KB Add to Briefcase
View Summary Myriad Genetics to Present At the Fourth Annual JMP Securities Healthcare Focus Conference
Sep 22, 2009
PDF 12.8 KB Add to Briefcase
View Summary Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors
Sep 21, 2009
PDF 14.8 KB Add to Briefcase
View Summary Myriad Genetics Launches Public Awareness Campaign in Five Midwest States to Reach Women with Increased Risk of Hereditary Breast and Ovarian Cancer
Sep 14, 2009
PDF 13.4 KB Add to Briefcase
View Summary Myriad Genetics to Present At the UBS Global Life Sciences Conference
Sep 8, 2009
PDF 12.8 KB Add to Briefcase
View Summary Myriad Genetics to Present At The Morgan Stanley Global Healthcare Conference
Aug 31, 2009
PDF 12.8 KB Add to Briefcase
View Summary Myriad Genetics Reports Fiscal 2009 Financial Results
Aug 25, 2009
PDF 20.2 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2009 Fourth Quarter and Year-End Financial Results On August 25
Aug 3, 2009
PDF 10.5 KB Add to Briefcase
View Summary Myriad Genetics Announces Completion of Spin Off of Its Research and Pharmaceutical Business
Jul 1, 2009
PDF 13.1 KB Add to Briefcase
View Summary Myriad Genetics Announces Preliminary Revenue Results for Fiscal 2009 Fourth Quarter, Full Year
Jun 30, 2009
PDF 11.3 KB Add to Briefcase
View Summary Myriad Genetics Announces Effectiveness of Myriad Pharmaceuticals Registration Statement on Form 10
Jun 11, 2009
PDF 10.3 KB Add to Briefcase
Showing 161-180 of 293 Page: 1 ... 5 6 7 8 9 10 11 12 13 ... 15  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
38.73
Change:
- 0.03
Open:
39.17
Previous Close:
38.75
Day High:
39.80
Day Low:
38.37
52 Week High:
42.50
52 Week Low:
20.02
Volume:
1,181,100
2:49 PM ET on Apr 16, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com